Depression treatment for Highland Beach — the full escalation pathway, 12 minutes away.

RECO Integrated Psychiatry sits seven miles north of Highland Beach — a twelve-minute drive up A1A from Bel Lido Isle or Toscana. The practice runs adequate antidepressant trials with documented PHQ-9 tracking, augments with aripiprazole, lithium, or T3 before switching, and delivers TMS and REMS-supervised Spravato on-site once treatment-resistant criteria are met. The escalation pathway is named at trial two, not trial four.

Highland Beach sits as a narrow oceanfront corridor between Delray and Boca Raton, and for residents along Bel Lido Isle, Toscana, or the condominium towers south of Linton Boulevard, the drive up A1A to RECO Integrated Psychiatry’s Delray Beach campus runs about seven miles and twelve minutes. That proximity matters clinically: depression treatment done properly requires frequent visits during titration, structured PHQ-9 monitoring, and — for treatment-resistant cases — on-site access to TMS and Spravato under REMS-compliant supervision. RECO delivers depression treatment as an integrated outpatient specialty rather than a fifteen-minute medication check bolted onto a general practice.

The diagnostic questions primary care doesn’t ask

Before a treatment plan is written for major depressive disorder, the psychiatrist has to rule out bipolar spectrum illness. This is not a checkbox — it is the difference between remission and iatrogenic harm. Antidepressant monotherapy in unrecognized bipolar II or cyclothymia induces mixed states, rapid cycling, and suicidality, and once the diagnostic error is embedded it often takes years and multiple hospitalizations to unwind. RECO’s initial evaluation uses the MDQ and HCL-32, a structured mood history including postpartum and substance-induced episodes, and family psychiatric history to catch bipolarity before a single SSRI is prescribed.

The same intake screens for the differential diagnoses that masquerade as depression. Undertreated OCD (screened with the YBOCS) presents as anhedonia and rumination. PTSD presents as emotional numbing and insomnia. Adult ADHD (ASRS) presents as demoralization and executive dysfunction. Thyroid dysfunction, obstructive sleep apnea, alcohol use disorder, and low-grade cannabis dependence all present in the psychiatrist’s office as “depression.” Treating the underlying condition rather than layering a fourth antidepressant is what separates specialist care from reflex prescribing.

First-line pharmacotherapy done well

An adequate antidepressant trial has a definition: a therapeutic dose sustained for six to eight weeks with documented adherence. Most treatment-resistant depression cases seen in consultation are not truly resistant — they are cases where prior trials were subtherapeutic, cut short, or abandoned when side effects were manageable. RECO starts sertraline, escitalopram, fluoxetine, venlafaxine XR, or duloxetine at a starting dose, titrates within two to four weeks to a therapeutic dose, and does not judge response until the trial has run its course. PHQ-9 is repeated at weeks two, four, six, and eight.

Agent selection is matched to the presentation. Bupropion is preferred where SSRI-induced sexual dysfunction, weight gain, or fatigue would predictably drive discontinuation, and where the depression is anergic rather than anxious. Mirtazapine is used for insomnia-predominant or appetite-suppressed presentations, particularly in older adults. Duloxetine covers comorbid neuropathic pain. Documented dose, duration, and PHQ-9 response — the three things insurance requires to authorize TMS or Spravato later, and the three things fragmented outpatient records usually lack.

Augmentation and switching after partial response

Partial responders — a meaningful but incomplete PHQ-9 reduction after an adequate trial — are augmented before they are switched. The evidence base favors this sequence. First-line augmentation options with the strongest data are aripiprazole at 2 to 15 mg, lithium titrated to a level of 0.4 to 0.8 mEq/L for augmentation (lower than the mood-stabilization target), and T3 at 25 to 50 mcg. Quetiapine XR and olanzapine are alternatives when sedation or anxiolysis is also needed, with the metabolic monitoring their use requires.

Bupropion augmentation of an SSRI is a rational choice for residual anergia, hypersomnia, or sexual side effects, and buspirone augmentation carries older but real evidence for residual anxiety. For non-responders — those with essentially no PHQ-9 movement — the literature does not support a within-class SSRI-to-SSRI switch as more than modestly effective. A cross-class switch to an SNRI, to bupropion, or to mirtazapine has better outcomes and is what RECO uses when the initial agent has genuinely failed rather than been under-dosed.

The interventional escalation pathway

After two adequate antidepressant trials at adequate dose and duration, a client meets the FDA and payer definition of treatment-resistant depression and becomes eligible for TMS or Spravato coverage. RECO’s protocol names the interventional option at trial two — not at trial four or five, which is where scattered outpatient care usually arrives. Repetitive TMS is delivered as a standard course of thirty-six sessions targeting the left dorsolateral prefrontal cortex, typically 3000 pulses per session at 120% of motor threshold, with response tracked weekly on the PHQ-9. TMS is the first choice for clients who prefer a non-systemic, non-sedating intervention and can commit to the daily-session schedule.

Esketamine (Spravato) is delivered on-site under the REMS program, with the two-hour post-dose monitoring and blood-pressure protocol the label requires. It fits clients who need rapid response — active suicidality, severe functional collapse — or who have failed TMS. IV ketamine is available as a cash-pay option where a compressed six-infusion induction is preferred. Escalation is planned at intake, not improvised after the third failed medication.

What the first visit looks like

The initial psychiatric evaluation runs sixty to ninety minutes. It covers presenting symptoms, full psychiatric history, prior medication trials with doses and outcomes, medical and thyroid history, substance use, family history, safety assessment, and a mental status examination. Rating scales — PHQ-9, GAD-7, MDQ, and ASRS or YBOCS where indicated — establish a baseline against which every subsequent visit is measured. Labs (CBC, CMP, TSH, vitamin D, B12, and where relevant a urine toxicology) are ordered where the differential requires them.

Adjunctive psychotherapy — CBT for the cognitive distortions and behavioral withdrawal that maintain depression, behavioral activation as its own protocol, ACT for values-driven engagement, EMDR where trauma is a driver — is coordinated with in-house and referred therapists rather than left to the client to arrange. Motivational interviewing frames adherence conversations when ambivalence about medication is part of the clinical picture.

Insurance and admissions from Highland Beach

RECO Integrated Psychiatry is in-network with Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS plans, which covers the majority of coverage held by Highland Beach residents. Verification of benefits is completed before the first visit so the client knows the copay for evaluations, medication management, TMS, and Spravato in advance. For Highland Beach residents, the twelve-minute drive up A1A means titration visits at weeks two, four, six, and eight are logistically realistic — the frequency that a proper antidepressant trial requires and that geographic distance quietly erodes.

Why the specialist model matters for depression

Depression that has not remitted on a first agent is not a general-practice problem — it is a sequencing problem, and the sequence is what psychiatric subspecialty training is for. RECO’s model concentrates the diagnostic screening, the adequate-trial documentation, the augmentation library, and the interventional escalation under one roof, so the client is not restarting the algorithm every time care changes hands.

Serving residents of: Bel Lido Isle, Boca Cove, Ocean Cove, Toscana, Penthouse.